Author:
Brandis Alexander S.,Salomon Yoram,Scherz Avigdor
Reference72 articles.
1. Borle F, Radu A, Fontolliet C, van den Bergh H, Monnier P and Wagnieres G (2003) Selectivity of the photosensitizer Tookad® for photodynamic therapy evaluated in the Sirian golden hamster cheek pouch tumour model. Br J Cancer 89:2320–2326
2. Chen L, Gross S, Rosenbach-Belkin V, Brandis A, Scherz A and Salomon Y (1998) Photoinactivation of microorganisms by chlorophyll-serine, bacteriochlorophyll-serine and by targeted bacteriochlorophyll-IgG. In: Patrice T (ed) IPA-98 Proceedings, RC-41. Ispen Biotech, Nantes (CD-ROM)
3. Chen Q, Huang Z, Luck D, Beckers J, Brun P-H, Wilson BC, Scherz A, Salomon Y and Hetzel FW (2002a) Preclinical studies in normal canine prostate of a novel palladium-bac-teriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancer. Photochem Photobiol 76:438–45
4. Chen Q, Huang Z, Luck D, Beckers J, Brun P-H, Wilson BC, Scherz A, Salomon Y and Hetzel FW (2002b) WST09 (TOOKAD) mediated photodynamic therapy as an alternative modality in the treatment of prostate cancer. Proc SPIE 4612:29–39
5. Chen Y, Graham A, Potter W, Morgan J, Vaughan LA, Bellnier DA, Henderson BW, Oseroff A, Dougherty TJ and Pandey RK (2002c) Bacteriopurpurinimides: Highly stable and potent photosensitizers for photodynamic therapy. J Med Chem 45:255–258
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献